When to Initiate Disease-Modifying Drugs for Relapsing Remitting Multiple Sclerosis in Adults?

Por Alkhawajah, Mona, Oger, Joel
Publicado em 2011

Escalating Immunotherapy of Multiple Sclerosis

Por Rieckmann, Peter, Traboulsee, Anthony, Devonshire, Virginia, Oger, Joel
Publicado em 2008

Adult celiac disease with acetylcholine receptor antibody positive myasthenia gravis

Por Freeman, Hugh J, Gillett, Helen R, Gillett, Peter M, Oger, Joel
Publicado em 2009

Synthesis of Nerve Growth Factor by L and 3T3 Cells in Culture

Por Oger, Joel, Arnason, Barry G. W., Pantazis, Nicholas, Lehrich, James, Young, Michael
Publicado em 1974

Evidence for a two-stage disability progression in multiple sclerosis

Por Leray, Emmanuelle, Yaouanq, Jacqueline, Le Page, Emmanuelle, Coustans, Marc, Laplaud, David, Oger, Joël, Edan, Gilles
Publicado em 2010

UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model

Por Palace, Jacqueline, Bregenzer, Thomas, Tremlett, Helen, Oger, Joel, Zhu, Fheng, Boggild, Mike, Duddy, Martin, Dobson, Charles
Publicado em 2014

Differences in interaction between immune complexes and complement receptors in serum and cerebrospinal fluid

Por Medof, M. Edward, Antel, Jack P., Oger, Joel J.-F., Prince, Gregory M., Arnason, Barry G. W.
Publicado em 1982

A longitudinal model for disease progression was developed and applied to multiple sclerosis

Por Lawton, Michael, Tilling, Kate, Robertson, Neil, Tremlett, Helen, Zhu, Feng, Harding, Katharine, Oger, Joel, Ben-Shlomo, Yoav
Publicado no J Clin Epidemiol (2015)

Modelling disease progression in relapsing-remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated...

Por Tilling, Kate, Lawton, Michael, Robertson, Neil, Tremlett, Helen, Zhu, Feng, Harding, Katharine, Oger, Joel, Ben-Shlomo, Yoav
Publicado no Health Technol Assess (2016)

Marginal Structural Cox Models for Estimating the Association Between β-Interferon Exposure and Disease Progression in a Multiple Sclerosis Cohort

Por Karim, Mohammad Ehsanul, Gustafson, Paul, Petkau, John, Zhao, Yinshan, Shirani, Afsaneh, Kingwell, Elaine, Evans, Charity, van der Kop, Mia, Oger, Joel, Tremlett, Helen
Publicado em 2014

Multiple Sclerosis in Older Adults: The Clinical Profile and Impact of Interferon Beta Treatment

Por Shirani, Afsaneh, Zhao, Yinshan, Petkau, John, Gustafson, Paul, Karim, Mohammad Ehsanul, Evans, Charity, Kingwell, Elaine, van der Kop, Mia L., Oger, Joel, Tremlett, Helen
Publicado no Biomed Res Int (2015)

Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study

Por Goodin, Douglas S, Ebers, George C, Cutter, Gary, Cook, Stuart D, O'Donnell, Timothy, Reder, Anthony T, Kremenchutzky, Marcelo, Oger, Joel, Rametta, Mark, Beckmann, Karola, Knappertz, Volker
Publicado em 2012

Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme

Por Palace, Jacqueline, Duddy, Martin, Lawton, Michael, Bregenzer, Thomas, Zhu, Feng, Boggild, Mike, Piske, Benjamin, Robertson, Neil P, Oger, Joel, Tremlett, Helen, Tilling, Kate, Ben-Shlomo, Yoav, Lilford, Richard, Dobson, Charles
Publicado no J Neurol Neurosurg Psychiatry (2019)

Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America

Por Green, Joshua D, Barohn, Richard J, Bartoccion, Emanuela, Benatar, Michael, Blackmore, Derrick, Chaudhry, Vinay, Chopra, Manisha, Corse, Andrea, Dimachkie, Mazen M, Evoli, Amelia, Florence, Julaine, Freimer, Miriam, Howard, James F, Jiwa, Theresa, Kaminski, Henry J, Kissel, John T, Koopman, Wilma J, Lipscomb, Bernadette, Maestri, Michelanglo, Marino, Mariapaola, Massey, Janice M, McVey, April, Mezei, Michelle M, Muppidi, Srikanth, Nicolle, Michael W, Oger, Joel, Pascuzzi, Robert M, Pasnoor, Mamatha, Pestronk, Alan, Provenzano, Carlo, Ricciardi, Roberta, Richman, David P, Rowin, Julie, Sanders, Donald B, Siddiqi, Zaeem, Soloway, Aimee, Wolfe, Gil I, Wulf, Charlie, Drachman, Daniel B, Traynor, Bryan J
Publicado no BMJ Open (2020)

Minimal manifestation status and prednisone withdrawal in the MGTX trial

Por Lee, Ikjae, Kuo, Hui-Chien, Aban, Inmaculada B., Cutter, Gary R., McPherson, Tarrant, Kaminski, Henry J., Sussman, Jon, Ströbel, Philipp, Oger, Joel, Cea, Gabriel, Heckmann, Jeannine M., Evoli, Amelia, Nix, Wilfred, Ciafaloni, Emma, Antonini, Giovanni, Witoonpanich, Rawiphan, King, John O., Beydoun, Said R., Chalk, Colin H., Barboi, Alexandru C., Amato, Anthony A., Shaibani, Aziz I., Katirji, Bashar, Lecky, Bryan R.F., Buckley, Camilla, Vincent, Angela, Dias-Tosta, Elza, Yoshikawa, Hiroaki, Waddington-Cruz, Marcia, Pulley, Michael T., Rivner, Michael H., Kostera-Pruszczyk, Anna, Pascuzzi, Robert M., Jackson, Carlayne E., Verschuuren, Jan J.G., Massey, Janice M., Kissel, John T., Werneck, Lineu C., Benatar, Michael, Barohn, Richard J., Tandan, Rup, Mozaffar, Tahseen, Conwit, Robin, Minisman, Greg, Sonett, Joshua R., Wolfe, Gil I.
Publicado no Neurology (2020)

Long-term effect of thymectomy in patients with non-thymomatous myasthenia gravis treated with prednisone: 2-year extension of the MGTX randomised trial

Por Wolfe, Gil I., Kaminski, Henry J., Aban, Inmaculada B., Minisman, Greg, Kuo, Hui-Chien, Marx, Alexander, Ströbel, Philipp, Mazia, Claudio, Oger, Joel, Gabriel Cea, J., Heckmann, Jeannine M., Evoli, Amelia, Nix, Wilfred, Ciafaloni, Emma, Antonini, Giovanni, Witoonpanich, Rawiphan, King, John O., Beydoun, Said R., Chalk, Colin H., Barboi, Alexandru C., Amato, Anthony A., Shaibani, Aziz I., Katirji, Bashar, Lecky, Bryan R. F., Buckley, Camilla, Vincent, Angela, Dias-Tosta, Elza, Yoshikawa, Hiroaki, Waddington-Cruz, Márcia, Pulley, Michael T., Rivner, Michael H., Kostera-Pruszczyk, Anna, Pascuzzi, Robert M., Jackson, Carlayne E., Verschuuren, Jan J.G.M., Massey, Janice M., Kissel, John T., Werneck, Lineu C., Benatar, Michael, Barohn, Richard J., Tandan, Rup, Mozaffar, Tahseen, Silvestri, Nicholas J., Conwit, Robin, Sonett, Joshua R., Jaretzki, Alfred, Newsom-Davis, John, Cutter, Gary R.
Publicado no Lancet Neurol (2019)

A Genome-wide Association Study of Myasthenia Gravis

Por Renton, Alan E., Pliner, Hannah A., Provenzano, Carlo, Evoli, Amelia, Ricciardi, Roberta, Nalls, Michael A., Marangi, Giuseppe, Abramzon, Yevgeniya, Arepalli, Sampath, Chong, Sean, Hernandez, Dena G., Johnson, Janel O., Bartoccioni, Emanuela, Scuderi, Flavia, Maestri, Michelangelo, Raphael Gibbs, J., Errichiello, Edoardo, Chiò, Adriano, Restagno, Gabriella, Sabatelli, Mario, Macek, Mark, Scholz, Sonja W., Corse, Andrea, Chaudhry, Vinay, Benatar, Michael, Barohn, Richard J., McVey, April, Pasnoor, Mamatha, Dimachkie, Mazen M., Rowin, Julie, Kissel, John, Freimer, Miriam, Kaminski, Henry J., Sanders, Donald B., Lipscomb, Bernadette, Massey, Janice M., Chopra, Manisha, Howard, James F., Koopman, Wilma J., Nicolle, Michael W., Pascuzzi, Robert M., Pestronk, Alan, Wulf, Charlie, Florence, Julaine, Blackmore, Derrick, Soloway, Aimee, Siddiqi, Zaeem, Muppidi, Srikanth, Wolfe, Gil, Richman, David, Mezei, Michelle M., Jiwa, Theresa, Oger, Joel, Drachman, Daniel B., Traynor, Bryan J.
Publicado no JAMA Neurol (2015)